published meta-analysis   sensitivity analysis   studies

standard of care in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias deathsdetailed resultsChen, ChiCTR2000030054 - Chloroquine, 2020 (REV) 1.52 [0.03; 82.26] 1.52[0.03; 82.26]Chen, ChiCTR2000030054 - Chloroquine, 2020 (REV)10%30NAnot evaluable adverse eventsdetailed resultsChen, ChiCTR2000030054 - Chloroquine, 2020 (REV) 0.52 [0.08; 3.26] 0.52[0.08; 3.26]Chen, ChiCTR2000030054 - Chloroquine, 2020 (REV)10%30NAnot evaluable0.22.01.0relative treatment effectwww.metaEvidence.org2024-05-26 08:08 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 651 - roots T: 651